Metabolic syndrome prevalence in postmenopausal and perimenopausal women – A cross-sectional study.

Pankajini  Behera; Suchismita  Panda; Mounica  Sahu; Mahija  Sahu

doi:10.51168/sjhrafrica.v6i6.1824

Authors

Pankajini Behera Postgraduate, Department of Obstetrics and Gynaecology, MKCG Medical College and Hospital, Berhampur, Odisha, India
Suchismita Panda Postgraduate, Department of Obstetrics and Gynaecology, MKCG Medical College and Hospital, Berhampur, Odisha, India
Mounica Sahu Postgraduate, Department of Obstetrics and Gynaecology, MKCG Medical College and Hospital, Berhampur, Odisha, India
Mahija Sahu Professor, Department of Obstetrics and Gynaecology, MKCG Medical College and Hospital, Berhampur, Odisha, India

DOI:

https://doi.org/10.51168/sjhrafrica.v6i6.1824

Keywords:

Premenopausal women, postmenopausal women, Metabolic syndrome, Menopause

Abstract

Background

Metabolic syndrome is influenced by factors such as weight gain, abdominal fat, high blood pressure, insulin resistance, and abnormal lipid and glucose levels. Additionally, lifestyle changes during menopause, including reduced physical activity and poor diet, contribute to its development.

Objectives- The main purpose of conducting this study is to compile the body of research on the prevalence of MetS in women who are perimenopausal or postmenopausal, emphasizing the risk factors and contributing variables.

Materials and Methods

The Maharaja Krushna Chandra Gajapati (MKCG) Medical College and Hospital in Berhampur, Odisha, India, was the site of this Observational study, which was carried out between May 2023 and October 2024 (one year and five months). After determining their eligibility based on the selection criteria, 200 women in the 40–60 age range—100 perimenopausal and 100 postmenopausal—were enlisted for the study. Participants have to be between the ages of 40 and 60 to be eligible.

Results

The results show a high prevalence of metabolic syndrome (MetS) among middle-aged women in the study. MetS prevalence was 89.2% in postmenopausal women and 76.5% in perimenopausal women. The overall prevalence of MetS in the population was 83.0%. These findings highlight a greater metabolic risk after menopause and the need for preventive health strategies in this age group.

Conclusion

The menopausal transition significantly impacts women's health, with 47% of perimenopausal women aged 40-49 and 45.5% of postmenopausal women over 50. Postmenopausal women had higher mean diastolic and systolic blood pressure, fasting blood sugar, and levels of triglyceride, as well as a greater prevalence of diabetes (25.0% vs. 7.0%) and hypertension (24.5% vs. 19.0%).

Recommendation

Regular health screenings and lifestyle modifications are recommended for middle-aged women to reduce the risk of metabolic syndrome.

References

Coyoy A, Guerra-Araiza C, Camacho-Arroyo I. Metabolism regulation by estrogens and their receptors in the central nervous system before and after menopause. Hormone and Metabolic Research. 2016 Aug;48(08):489-96.

Davis SR, Lambrinoudaki I, Lumsden M, Mishra GD, Pal L, Rees M, Santoro N. 649 Simoncini T. Menopause. Nat Rev Dis Primers. 2015;1:15004. https://doi.org/10.1038/nrdp.2015.4 PMid:27188659

Federation ID. The IDF consensus worldwide definition of the metabolic syndrome. IDF Communications. 2006:1-24.

Gadelha AB, Myers J, Moreira S, Dutra MT, Safons MP, Lima RM. Comparison of adiposity indices and cut-off values in the prediction of metabolic syndrome in postmenopausal women. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2016 Jul 1;10(3):143-8. https://doi.org/10.1016/j.dsx.2016.01.005 PMid:26810157

Karlamangla AS, Burnett-Bowie SA, Crandall CJ. Bone health during the menopause transition and beyond. Obstetrics and Gynecology Clinics of North America. 2018 Oct 25;45(4):695. https://doi.org/10.1016/j.ogc.2018.07.012 PMid:30401551 PMCid:PMC6226267

Kaur, Sukhpal & Singh, Bhim & Saini, Sushma & Sikka, Pooja & Saha, Pradeep & Rawat, Sarita. A cross-sectional study to estimate the health care needs of perimenopausal and postmenopausal women. Indian Journal of Obstetrics and Gynecology Research. 2024; 11: 374-380. https://doi.org/10.18231/j.ijogr.2024.068

Khanam MA, Qiu C, Lindeboom W, Streatfield PK, Kabir ZN, Wahlin Å. The metabolic syndrome: prevalence, associated factors, and impact on survival among older persons in rural Bangladesh. PLoS One. 2011 Jun 15;6(6):e20259. https://doi.org/10.1371/journal.pone.0020259 PMid:21697988 PMCid:PMC3115931

Li Q, Wang X, Ni Y, Hao H, Liu Z, Wen S, Shao X, Wu X, Yu W, Hu W. Epidemiological characteristics and risk factors of T2DM in Chinese premenopausal and postmenopausal women. Lipids in Health and Disease. 2019 Dec;18:1-8. https://doi.org/10.1186/s12944-019-1091-7 PMid:31315681 PMCid:PMC6637604

Meirelles RM. Menopause and metabolic syndrome. Arquivos Brasileiros de Endocrinologia & Metabologia. 2014;58:91-6. https://doi.org/10.1590/0004-2730000002909 PMid:24830585

Morselli E, Santos RS, Criollo A, Nelson MD, Palmer BF, Clegg DJ. The effects of oestrogens and their receptors on cardiometabolic health. Nature Reviews Endocrinology. 2017 Jun;13(6):352-64. https://doi.org/10.1038/nrendo.2017.12 PMid:28304393

Napoleone JM, Boudreau RM, Lange-Maia BS, El Khoudary SR, Ylitalo KR, Kriska AM, Karvonen-Gutierrez CA, Strotmeyer ES. Metabolic syndrome trajectories and objective physical performance in mid-to-early late life: the Study of Women's Health Across the Nation (SWAN). The Journals of Gerontology: Series A. 2022 Feb 1;77(2):e39-47. https://doi.org/10.1093/gerona/glab188 PMid:34216218 PMCid:PMC8824556

Prasad JB, Tyagi NK, Verma P. Age at menopause in India: A systematic review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021 Jan 1;15(1):373-7. https://doi.org/10.1016/j.dsx.2021.01.013 PMid:33524647

Saklayen MG. The global epidemic of the metabolic syndrome. Current hypertension reports. 2018 Feb;20(2):1-8.

Suliga E, Kozieł D, Cieśla E, Rębak D, Głuszek S. Factors associated with adiposity, lipid profile disorders and the metabolic syndrome occurrence in premenopausal and postmenopausal women. PLoS One. 2016 Apr 29;11(4):e0154511. https://doi.org/10.1371/journal.pone.0154511 PMid:27128677 PMCid:PMC4851395

Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Translational Research. 2017 May 1;183:57-70. https://doi.org/10.1016/j.trsl.2017.01.001 PMid:28130064 PMCid:PMC5393930

World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation.

Zuo H, Shi Z, Hu X, Wu M, Guo Z, Hussain A. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism. 2009 Aug 1;58(8):1102-8. https://doi.org/10.1016/j.metabol.2009.04.008 PMid:19481771